Psychedelics and biotech company ATAI Life Sciences announced Wednesday the launch of Viridia Life Sciences.
This wholly-owned subsidiary will be dedicated to the study and production of the DMT molecule (N,N-Dimethyltryptamine).
DMT is a psychoactive alkaloid present in Ayahuasca, a hallucinogenic brew traditionally used by indigenous communities in South America. The compound has gained attention in recent decades in North America for its ability to induce psychedelic experiences with a rapid onset and shorter duration than other psychedelic drugs.
Exploring Alternative Routes Of Administration
Most common applications of …